Know Cancer

or
forgot password

Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy


N/A
18 Years
N/A
Open (Enrolling)
Both
Neoplasms

Thank you

Trial Information

Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy


Inclusion Criteria:



- Patients older than 18-year-old, diagnosed with cancer

- Patients must understand and voluntarily sign an Informed Consent form after the
contents have been fully explained to them

Exclusion Criteria:

- Patients who cannot complete a PET/CT scan

- Pregnant women

- Healthy volunteers

- Patients participating in other research studies

The subjects will not be paid to participate in this protocol. No costs will be charged to
the subjects.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Percent of patients with evidence of new lesions on combined F-18/F-18 FDG PET/CT.

Outcome Time Frame:

not defined

Safety Issue:

No

Principal Investigator

Sanjiv Sam Gambhir M.D., Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

VAR0024

NCT ID:

NCT00725387

Start Date:

August 2007

Completion Date:

December 2014

Related Keywords:

  • Neoplasms
  • Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317